Day: September 23, 2024

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. SAN DIEGO, CA, Sept. 23, 2024 (GLOBE NEWSWIRE) — Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on September 25, 2024 (https://emerginggrowth.com/conference/). This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Dr. David Koos, in real time. Please ask your questions during the event and Dr. Koos and his team will do their best to get...

VANCOUVER, British Columbia, Sept. 23, 2024 (GLOBE NEWSWIRE) — URZ3 Energy Corp. (“URZ” or the “Company”) (TSX-V: URZ; OTCQB: NVDEF) announces with great sadness the passing of Company director Ben Leboe – our wonderful friend, mentor and business partner. An experienced director and business executive, Ben was a Chartered Professional Accountant (CPA, CA), business valuator and management consultant. After beginning his career with KPMG, he went on to serve as the Chief Financial Officer to many organizations, among them Uranerz Energy Corp., and held many directorships, including with URZ Energy Corp. As much or more than his expert advice and considerable business acumen, we valued Ben’s calm wisdom, unassuming style, generous mentorship, quick wit and wise perspective. A devoted husband and father, we are grateful Ben...

Company Files Annual 10-K Report with Full Financial Results MIAMI, Sept. 23, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (OTC: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced significant progress in strengthening its balance sheet following a series of restructuring initiatives over the past several quarters. The Company has significantly improved its financial position, transitioning from negative net stockholders’ equity to over $9.4 million in positive net stockholders’ equity as of September 20, 2024. The Company also announced that it has successfully filed its 2023 annual report on Form 10-K with the U.S. Securities and Exchange Commission. This financial...

Agreement includes an exclusive partnership to provide solar as an included feature in all Toll Brothers communities in California FORT WASHINGTON, Pa., Sept. 23, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, and Sunrun Inc., America’s #1 home solar and storage provider, today announced a new national partnership for Sunrun to provide solar power and storage to Toll Brothers homes. Sunrun and Toll Brothers have an exclusive agreement for Sunrun to provide solar power as an included feature in all Toll Brothers homes in California, as well as a preferred agreement to provide solar for additional Toll Brothers divisions nationwide. As part of the agreement, Sunrun will serve as a “one-stop shop” to provide solar as a standard feature in all Toll Brothers communities in California,...

WISeKey Announces OISTE’s Participation at the Summit of the Future New York, New York – September 23, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leader in cybersecurity, AI, Blockchain, and IoT operating as a holding company, today announced that OISTE.org, a non-governmental organization, recently participated in a pivotal event at the UN Headquarters in New York, where world leaders gathered for the Summit of the Future. OISTE holds special consultative status with the United Nations Economic and Social Council (ECOSOC) and actively engages with multiple key international bodies, such as the Human Rights Council, the International Telecommunications Union, Clinton Initiative and the World Summit on the Information Society (WSIS). These interactions position OISTE as a significant player...

PITTSBURGH, Sept. 23, 2024 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a leader in materials, networking, and lasers, will participate in multiple panels and workshops at the European Conference on Optical Communications (ECOC) 2024 in Frankfurt, Germany, September 22-24. Coherent technologies and products are found in communications networks from the depths of the world’s oceans to earth orbit and beyond. Coherent thought leaders will share key insights, highlight market-leading technologies, and provide a forward-looking view on the major trends shaping the future of the industry. Coherent continues to set new standards in optical networking equipment, enabling advanced AI systems and global connectivity. WORKSHOPS Massively Parallel Optical Transceivers and Interfaces – Where Are We on This Path?Speaker: Vipul Bhatt, VP,...

Châtillon, France, September 23, 2024 DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial In Q3 2024, DBV exceeded its recruitment goal and successfully closed the screening process for the VITESSE Phase 3 study evaluating the Viaskin® Peanut Patch in peanut allergic children ages 4 – 7 years old Topline results of VITESSE data are expected by Q4 2025 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that patient screening is complete for the Phase 3 trial, VITESSE (Viaskin Peanut Immunotherapy Trial to Evaluate Safety, Simplicity and Efficacy), using the modified Viaskin Peanut Patch in children ages 4 – 7 years old with peanut allergy. “We are thrilled to have reached this significant milestone,” said Dr. Pharis Mohideen,...

HANGZHOU, China, Sept. 23, 2024 (GLOBE NEWSWIRE) — Nano Labs Ltd (Nasdaq: NA) (“we,” “the Company,” or “Nano Labs”), a leading fabless integrated circuit design company and product solution provider in China, today announced that it will hold its 2024 Annual General Meeting of Shareholders (the “2024 Annual Meeting”) at 10 A.M. on October 23, 2024, Beijing time (10 P.M. on October 22, 2024, U.S. Eastern time) in China Yuangu Hanggang Technology Building, 509 Qianjiang Road, Shangcheng District, Hangzhou, Zhejiang, 310000, People’s Republic of China. The Company has established the close of business on September 27, 2024, Eastern time (the “Record Date”), as the record date for determining shareholders entitled to notice of, and to vote at, the Meeting and any adjournments or postponements thereof. The purpose of the Meeting...

BROSSARD, Quebec, Sept. 23, 2024 (GLOBE NEWSWIRE) — In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK), announces that as a result of the issuance of 8,333,333 common shares (each, a “Share”) as part of a private placement of units announced on September 20, 2024, Mr. Tristram Coffin ceased to be an insider of the Corporation since his ownership dropped below 10%. Immediately before the issuance of the Shares, Mr. Coffin exercised control, directly and indirectly, over 8,180,234 Shares of the Issuer, representing ownership of 10.04% on an undiluted basis. The issuance of the Shares remains subject to the TSX Venture approval. About DIAGNOS DIAGNOS is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through...